Skip Navigation
Skip to contents

ICoLA 2019

Today : 2019.08.26
D- 10
The 8th International Congress on Lipid & Atherosclerosis (ICoLA)
The 58th Fall Conference of the Korean Society of Lipid & Atherosclerosis
September 5 (Thu) ~ 7 (Sat), 2019
Conrad Seoul Hotel, Korea

Luncheon Symposia

  • HOME
  • Program
  • Luncheon Symposia

*(K) Korean Session

LUNCHEON SYMPOSIUM 1
Sep. 6 (Fri.)
12:10~13:10
Room 1

more

Chairperson Cheol Ho Kim (Seoul National University, Korea)
12:10-12:30 Optimizing Risk Reduction Strategies in Patients with Diabetes and Atherosclerotic Cardiovascular Disease Robert S. Rosenson (The Mount Sinai Hospital in New York, USA) Abstract
12:30-12:50 The Evidence of Using Metformin as a Treatment for Patients with Type 2 Diabetes Hye Soon Kim (Keimyung University, Korea) Abstract
LUNCHEON SYMPOSIUM 2
Sep. 6 (Fri.)
12:10~13:10
Room 2

more

Chairperson Hyun Chul Lee (Yonsei University, Korea)
12:10-12:40 The Additional Benefits of Anagliptin Beyond Glycemic Control Jun Hwa Hong (Eulji University, Korea) Abstract
LUNCHEON SYMPOSIUM 3
Sep. 6 (Fri.)
12:10~13:10
Room 3

more

Chairperson Kwang-Won Kim (Gachon University, Korea)
12:10-12:40 Additional Benefits of Rosuvastatin/Ezetimibe Combination Therapy Yong-ho Lee (Yonsei University, Korea) Abstract
LUNCHEON SYMPOSIUM 4
Sep. 6 (Fri.)
12:10~13:10
Room 4

more

Chairperson Ho Young Son (The Catholic University of Korea, Korea)
12:10-12:30 Advantages of Rosuvastatin and Ezetimibe Combination Treatment Moo-Yong Rhee (Dongguk University, Korea) Abstract
12:30-12:50 Evidence-Based Approach for Ideal Hypertension Management Soon Jun Hong (Korea University, Korea)
LUNCHEON SYMPOSIUM 5
Sep. 7 (Sat.)
12:10~13:10
Room 1

more

Chairperson Hong Kyu Lee (Eulji University, Korea)
12:10-12:30 Different Approach, Different Result in T2DM Focusing on SGLT2 Inhibitor Soo Lim (Seoul National University, Korea) Abstract
12:30-12:50 Maintaining Stable Glycemic Control for Type 2 Diabetes : Why Is It Important? So Hun Kim (Inha University, Korea) Abstract
LUNCHEON SYMPOSIUM 6
Sep. 7 (Sat.)
12:10~13:10
Room 2

more

Chairperson Dong Soo Kim (Inje University, Korea)
12:10-12:40 Current and Future Lipid Treatment through Recent Key Outcomes Anselm K. Gitt (Ludwigshafen University, Germany) Abstract
LUNCHEON SYMPOSIUM 7
Sep. 7 (Sat.)
12:10~13:10
Room 3

more

Chairperson Yeong Gil Choi (Kyung Hee University, Korea)
12:10-12:30 Comprehensive Data from Empagliflozin : How These Results Translate into Routine Clinical Practice? Stefano Del Prato (University of Pisa, Italy)
12:30-12:50 The Impact of Empagliflozin beyond Glucose Control : from Mechanism to Outcome Kausik Ray (Imperial College London, UK) Abstract
LUNCHEON SYMPOSIUM 8
Sep. 7 (Sat.)
12:10~13:10
Room 4

more

Chairperson Kyoo-Rok Han (Hallym University,Korea)
12:10-12:40 Recent Updates in Hypertension Goals: What does the Physician Need to Know? Sanjay Rajagopalan (Case Western Reserve University, USA) Abstract
Organized by KSoLA

The Korean Society of Lipid and Atherosclerosis

No.707, Mapoacro Tower, 68 Mapo-daero, Mapo-gu, Seoul 04168, Korea
  • Business Registration Number : 110-82-60956
  • Chairman : Joong-Yeol Park

Secretariat of ICoLA 2019 │ People & Value, Inc.

#1001 Botanic Park Tower, Magok-joongang-ro 161-17, Gangseo-gu, Seoul, Korea

Copyrights 2019 © The Korean Society of Lipid and Atherosclerosis. All rights reserved.